DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association Paris Stock Exchange:DBV

Press/Media

Period22 Feb 2019

Media coverage

1

Media coverage

  • TitleDBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association Paris Stock Exchange:DBV
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date22/02/19
    PersonsKurt Hirschhorn
View all 1
View less